skip to navigation skip to content
search
  • About us
    • Who we are
    • Horizon scanning
    • Public involvement
      • Public Involvement Network Advisory Group
      • Patient group partners
      • Public partners
    • Policies & publications
    • Minutes
    • Meetings
    • Register for a meeting
    • ILAP
    • Latest update
    • Contact us
  • Medicines advice
  • How we decide
    • PACE
    • Interim acceptance decision option
    • Ultra-orphan medicines for extremely rare conditions
    • Abbreviated submissions
  • Making a submission
Pills image

Policies & publications

  • Home
  • /
  • About us
  • /
  • Policies & publications

SMC guides and reports

General overview guides and reports on our work

  • A guide to the Scottish Medicines Consortium (PDF, 3MB)
  • SMC update report (PDF, 2MB)
  • Guide For Patient Group Partners 2022 (PDF, 1MB)

SMC policies

Policies relating to our processes and procedures

  • Modifiers (PDF, 158KB)
  • Guide to quality adjusted life years (QALYs) (PDF, 425KB)
  • Process For Issuing Not Recommended Advice Due To Non Submission (DOCX, 153KB)
  • Company disagreement on medicines not validated as ultra-orphan.pdf (PDF, 313KB)
  • Re-evaluation of SMC decisions (PDF, 179KB)

SMC policies: company submissions

Our policies and procedures around submissions made by pharmaceutical companies

  • NDC Clinical checklist (DOCX, 180KB)
  • Release of company data (PDF, 563KB)
  • Consultation with competitor companies (PDF, 183KB)

Revised process for ultra-orphan medicines

Following the Scottish Government's announcement in June 2018 a new approach to the assessment of ultra-orphan medicines has been introduced.

Find out more

Declarations of interest

Declarations of interest for SMC are aligned with Healthcare Improvement Scotland Evidence Directorate policies.

Click the link to view the definitions and policies.

Scottish Government policies

Policies set by Scotland's devolved government

  • The introduction and availability of medicines (PDF, 142KB)
  • Safe and effective use of new medicines (PDF, 116KB)
  • Contact us
  • Register for a meeting
  • Accessibility
  • Terms and conditions
  • Respecting your privacy
  • Freedom of information

© Scottish Medicines Consortium

  • NHS Scotland Logo